Free Trial

P3 Health Partners (PIII) Competitors

P3 Health Partners logo
$0.20 +0.01 (+4.72%)
(As of 12/20/2024 05:51 PM ET)

PIII vs. PSNL, LFMD, BDSX, EUDA, QIPT, XGN, BNR, ENZ, CCM, and TOI

Should you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Personalis (PSNL), LifeMD (LFMD), Biodesix (BDSX), EUDA Health (EUDA), Quipt Home Medical (QIPT), Exagen (XGN), Burning Rock Biotech (BNR), Enzo Biochem (ENZ), Concord Medical Services (CCM), and Oncology Institute (TOI). These companies are all part of the "healthcare" industry.

P3 Health Partners vs.

Personalis (NASDAQ:PSNL) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

61.9% of Personalis shares are held by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are held by institutional investors. 4.1% of Personalis shares are held by insiders. Comparatively, 17.9% of P3 Health Partners shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Personalis currently has a consensus target price of $7.31, indicating a potential upside of 27.17%. P3 Health Partners has a consensus target price of $2.38, indicating a potential upside of 1,103.75%. Given P3 Health Partners' higher possible upside, analysts plainly believe P3 Health Partners is more favorable than Personalis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Personalis
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
P3 Health Partners
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

P3 Health Partners has a net margin of -6.95% compared to Personalis' net margin of -104.52%. Personalis' return on equity of -66.07% beat P3 Health Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Personalis-104.52% -66.07% -41.34%
P3 Health Partners -6.95%-71.31%-11.93%

In the previous week, Personalis had 10 more articles in the media than P3 Health Partners. MarketBeat recorded 11 mentions for Personalis and 1 mentions for P3 Health Partners. Personalis' average media sentiment score of 0.33 beat P3 Health Partners' score of 0.00 indicating that Personalis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Personalis
0 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
P3 Health Partners
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

P3 Health Partners has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Personalis$87.49M4.64-$108.30M-$1.68-3.42
P3 Health Partners$1.48B0.05-$57.77M-$0.84-0.23

Personalis received 113 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 66.86% of users gave Personalis an outperform vote while only 26.67% of users gave P3 Health Partners an outperform vote.

CompanyUnderperformOutperform
PersonalisOutperform Votes
117
66.86%
Underperform Votes
58
33.14%
P3 Health PartnersOutperform Votes
4
26.67%
Underperform Votes
11
73.33%

Personalis has a beta of 1.88, indicating that its share price is 88% more volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500.

Summary

Personalis beats P3 Health Partners on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PIII vs. The Competition

MetricP3 Health PartnersHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$70.80M$867.07M$5.13B$9.08B
Dividend YieldN/A1.90%4.91%4.22%
P/E Ratio-0.2332.2091.4117.18
Price / Sales0.053.751,113.85116.83
Price / Cash2.3625.1442.7137.86
Price / Book0.442.924.794.78
Net Income-$57.77M-$5.79M$120.07M$225.60M
7 Day Performance-3.76%-4.93%-1.91%-1.23%
1 Month Performance-10.15%-4.89%11.46%3.36%
1 Year Performance-83.28%226.77%30.54%16.59%

P3 Health Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PIII
P3 Health Partners
2.3874 of 5 stars
$0.20
+4.7%
$2.38
+1,103.8%
-83.0%$70.80M$1.48B-0.23500News Coverage
PSNL
Personalis
3.9661 of 5 stars
$3.79
-0.8%
$6.81
+79.7%
+293.8%$267.76M$73.48M-2.27400Analyst Forecast
News Coverage
Gap Up
LFMD
LifeMD
1.4049 of 5 stars
$5.73
+0.7%
$11.57
+101.9%
-37.0%$248.18M$193.06M-8.89230Positive News
BDSX
Biodesix
2.56 of 5 stars
$1.34
-0.4%
$3.06
+129.2%
-4.8%$194.20M$65.56M-3.44220
EUDA
EUDA Health
0.3167 of 5 stars
$5.42
-9.1%
N/A+246.2%$133.48M$3.81M0.002
QIPT
Quipt Home Medical
2.5539 of 5 stars
$3.06
+1.7%
$6.25
+104.2%
-49.5%$131.86M$221.74M-27.361,200Earnings Report
Analyst Revision
News Coverage
XGN
Exagen
4.6619 of 5 stars
$6.03
+4.3%
$7.00
+16.1%
+191.0%$106.37M$52.55M-6.14220High Trading Volume
BNR
Burning Rock Biotech
1.9752 of 5 stars
$6.75
+0.3%
N/A-12.3%$69.15M$510.89M-2.241,390Positive News
ENZ
Enzo Biochem
0.7816 of 5 stars
$1.02
flat
N/A-46.7%$53.29M$31.91M0.00520Earnings Report
Analyst Forecast
CCM
Concord Medical Services
0.3784 of 5 stars
$4.89
-1.2%
N/A-58.8%$21.23M$471.70M0.00970Analyst Forecast
News Coverage
TOI
Oncology Institute
2.5295 of 5 stars
$0.21
-5.8%
$2.50
+1,090.5%
-88.1%$15.87M$378.93M-0.29660

Related Companies and Tools


This page (NASDAQ:PIII) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners